| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $2.25 | $1.72 | $1.67 | $4.02 | $3.87 | $1.46 | $0.45 | $1.28 |
| EPS (Diluted) | $2.23 | $1.69 | $1.64 | $3.92 | $3.71 | $1.43 | $0.44 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.1B | $12.9B | $11.3B | $9.9B | $8.2B | $7.9B | $4.8B | $3.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.9B | $11.9B | $10.4B | $9.0B | $7.5B | $7.3B | $4.3B | $3.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.2B | $1.0B | $0.9B | $0.8B | $0.7B | $0.6B | $0.5B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.5B | $0.6B | $0.1B | $-0.1B | $-0.3B | $-0.5B | $0.0B |
| Investing Cash Flow | $-1.9B | $-2.1B | $-1.8B | $-1.4B | $-0.1B | $-2.6B | $-0.7B | $-0.9B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B |
| Financing Cash Flow | $2.0B | $1.6B | $1.3B | $1.5B | $0.2B | $3.0B | $1.1B | $0.9B |